Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
3(75.0%)
Phase 1
1(25.0%)
4Total
Phase 2(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05732623Recruiting

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

Role: collaborator

NCT07549646Phase 2Active Not Recruiting

24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs

Role: collaborator

NCT07543822Phase 2Active Not Recruiting

24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs

Role: collaborator

NCT07307768Phase 1Not Yet Recruiting

Ketamine Biomarker Validation

Role: collaborator

NCT07287839Phase 2Not Yet Recruiting

Parcel-guided rTMS for Major Depressive Disorder

Role: collaborator

All 5 trials loaded